Medicine and Dentistry
Breast Cancer
100%
Osteoporosis
100%
Osteolysis
57%
Bisphosphonate
42%
Adjuvant Chemotherapy
28%
Premenopause
28%
Cost-Effectiveness Analysis
28%
Patient Population
14%
Prophylaxis
14%
Retroperitoneal Lymph Node Dissection
14%
Alendronic Acid
14%
Estrogen Deficiency
14%
Toxicity
14%
Bone Turnover
14%
Public Health
14%
Health Care Cost
14%
Cancer Therapy
14%
Quality of Life
14%
Menadione
14%
Randomized Controlled Trial
14%
Clinical Research
14%
Nursing and Health Professions
Breast Cancer
100%
Bisphosphonic Acid Derivative
42%
Cost Effectiveness Analysis
28%
Adjuvant Chemotherapy
28%
Quality of Life
14%
Lymph Node Dissection
14%
Estrogen Deficiency
14%
Cancer Therapy
14%
Patient Population
14%
Toxicity
14%
Prophylaxis
14%
Alendronic Acid
14%
Menadione
14%
Bone Turnover
14%
Nutrition Policy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Chemotherapy
85%
Bisphosphonic Acid Derivative
42%
Toxicity
14%
Malignant Neoplasm
14%
Alendronic Acid
14%
Randomized Controlled Trial
14%
Estrogen Deficiency
14%
Menadione
14%
Clinical Research
14%